Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-masked, Placebo- and Active- Controlled, Parallel-group, Multi-center, Dose-response Trial of DE-104 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension

NCT00650338 is registered in ClinicalTrials.gov with Santen Inc. as lead sponsor.

NCT NCT00650338
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00650338 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-masked, Placebo- and Active- Controlled, Parallel-group, Multi-center, Dose-response Trial of DE-104 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
Lead sponsor
Santen Inc.
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2008
Completion date
October 31, 2008
Enrollment
165 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

ocular hypertension, open-angle glaucoma